Lung volume-based stratification in TEPS identifies biologically distinct subgroups with differing plasma proteomic signature and COPD risk, underscoring the heterogeneity of early disease and revealing potential circulating biomarkers of pre-COPD states.
Zeng et al. (Tue,) studied this question.